Search clinical trials for: ICRS
Total 201 results
-
Schaper & Bruemmer GmbH & Co KGCompleted
-
Novartis PharmaceuticalsCompletedCOPDGermany, Belgium, Poland, Romania, Italy, Spain, Estonia, Russian Federation, Austria, France, Slovakia, Czechia, Latvia, Lithuania, Greece, Hungary, United Kingdom, Portugal, Ireland, Norway, Slovenia, Denmark, Sweden
-
Aduro Biotech, Inc.Johns Hopkins UniversityCompleted2nd-line, 3rd-line and Greater Metastatic Pancreatic CancerUnited States, Canada
-
Nanfang Hospital of Southern Medical UniversityUnknown
-
Boehringer IngelheimCompleted
-
Medical College of WisconsinRecruitingCardiovascular Diseases | Estrogen | MicrovasculatureUnited States
-
Boehringer IngelheimCompleted
-
Shanghai Pulmonary Hospital, Shanghai, ChinaCompleted
-
Novartis PharmaceuticalsCompleted
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveChina
-
Boehringer IngelheimHealthCore-NERICompleted
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveUnited States
-
Dr. Grace ParragaNovartis PharmaceuticalsWithdrawn
-
University of California, San FranciscoLondon School of Hygiene and Tropical Medicine; University of Texas Southwestern... and other collaboratorsCompleted
-
Uppsala UniversityCompletedColorectal Peritoneal CarcinomatosisSweden
-
Nemours Children's ClinicWithdrawnSafety of Long Acting Beta Agnoists
-
Hvidovre University HospitalRecruiting
-
Ziekenhuis Oost-LimburgCompletedPseudomyxoma Peritonei | Peritoneal Carcinomatosis | Mesothelioma; Peritoneum
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveGermany, Netherlands, Greece, Czechia
-
National Institute of Allergy and Infectious Diseases...Inner-City Asthma ConsortiumCompletedAsthmaUnited States
-
Cancer Institute and Hospital, Chinese Academy...RecruitingSafety Assessment of Concurrent Radiotherapy and Novel Systemic Therapy for Breast Cancer (RADIOCOM)Chemotherapeutic Toxicity | Radiotherapy; Complications | PARP Inhibitor | Immune Checkpoint Inhibitor | Trastuzumab | Breast Cancer, Familial Male | CDK4/6 Inhibitor | PertuzumabChina
-
Aduro Biotech, Inc.CompletedMalignant Pleural MesotheliomaUnited States
-
SanofiRegeneron PharmaceuticalsCompletedAsthmaSpain, Canada, United States, Korea, Republic of, Mexico, Brazil, Germany, Taiwan, Argentina, Australia, Colombia, France, Hungary, Japan, Poland, Russian Federation, South Africa, Turkey, Ukraine, United Kingdom, Italy, Chile
-
Children's Hospital of PhiladelphiaCompleted
-
Sidney Kimmel Comprehensive Cancer Center at Johns...National Cancer Institute (NCI); Merck Sharp & Dohme LLCActive, not recruitingMetastatic Pancreatic AdenocarcinomaUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Bristol-Myers Squibb; Stand Up To Cancer; Aduro Biotech, Inc.; American Association... and other collaboratorsCompletedPreviously Treated Metastatic Adenocarcinoma of the PancreasUnited States
-
SanofiRegeneron PharmaceuticalsCompletedAsthmaSpain, United States, Chile, Australia, France, Mexico, Argentina, Italy, Japan, Poland, Russian Federation, South Africa, Turkey, Ukraine, Korea, Republic of, New Zealand
-
Mundipharma Pharmaceuticals S.L.Alpha Bioresearch S.L.; Dynamic SolutionsWithdrawn
-
Washington University School of MedicineNational Institutes of Health (NIH); National Center for Advancing Translational...RecruitingAsthma | Nonadherence, MedicationUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Bristol-Myers Squibb; National Cancer Institute (NCI); Aduro Biotech, Inc.CompletedPancreatic CancerUnited States
-
Washington University School of MedicineNational Institutes of Health (NIH); National Center for Advancing Translational...RecruitingAsthma in Children | Nonadherence, MedicationUnited States
-
Charles Porter, MDMedtronicCompletedHeart Failure; With DecompensationUnited States
-
Daping Hospital and the Research Institute of Surgery...CompletedChronic Obstructive Pulmonary DiseaseChina
-
NovartisCompleted
-
Far Eastern Memorial HospitalResearch Ethics Review CommitteeUnknownQuality of Life | Percentage of Annual Acute ExacerbationTaiwan
-
SanofiRegeneron PharmaceuticalsCompletedAsthmaBelgium, Israel, United States, Mexico, Argentina, Brazil, Canada, Chile, Colombia, Hungary, Italy, Netherlands, Poland, Romania, Russian Federation, Spain, Ukraine
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic Obstructive
-
University Hospital MuensterMedical Research CouncilUnknown
-
Children's Oncology GroupNational Cancer Institute (NCI); Children's Cancer GroupCompletedLymphoma | Cardiac ToxicityUnited States, Australia, Canada
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedSarcoma | Cardiac ToxicityUnited States, Canada, Netherlands, Puerto Rico, Switzerland, Australia
-
Fundacio Privada Mon Clinic BarcelonaGlaxoSmithKlineRecruiting
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedLymphoma | Cardiac ToxicityUnited States, Canada, Switzerland
-
Children's Oncology GroupNational Cancer Institute (NCI)Active, not recruitingLocalized Extraskeletal Ewing Sarcoma | Peripheral Primitive Neuroectodermal Tumor of Bone | Peripheral Primitive Neuroectodermal Tumor of Soft TissuesUnited States, Canada, Saudi Arabia, Australia, New Zealand, Puerto Rico
-
National Cancer Institute (NCI)Active, not recruitingPRETEXT I Hepatoblastoma | PRETEXT II Hepatoblastoma | PRETEXT III Hepatoblastoma | PRETEXT IV HepatoblastomaUnited States, Canada, Puerto Rico, Australia, Japan, Brazil
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)Completed
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedLymphoma | Leukemia | Cardiac Toxicity
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedSarcomaCanada, United States, Australia, Puerto Rico
-
National Cancer Institute (NCI)Active, not recruitingGanglioneuroblastoma | High Risk NeuroblastomaUnited States, New Zealand, Australia